TNIP1 Antikörper (C-Term)
Kurzübersicht für TNIP1 Antikörper (C-Term) (ABIN955281)
Target
Alle TNIP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 454-482, C-Term
-
Spezifität
- This antibody detects TNIP1 (C-term).
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human
-
Aufreinigung
- Protein A column followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 454-482 amino acids from the C-terminal region of human TNIP1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer.
-
-
- TNIP1 (TNFAIP3 Interacting Protein 1 (TNIP1))
-
Andere Bezeichnung
- TNIP1
-
Hintergrund
- Interacts with zinc finger protein A20/TNFAIP3 and inhibits TNF-induced NF-kappa-B-dependent gene expression by interfering with an RIP-or TRAF2-mediated transactivation signal (By similarity). Increases cell surface CD4(T4) antigen expression. Interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. May regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production.Synonyms: HIV-1 Nef-interacting protein, KIAA0113, NAF1, Nef-associated factor 1, Nip40-1, TNFAIP3-interacting protein 1, VAN, Virion-associated nuclear shuttling protein
-
Gen-ID
- 10318
-
NCBI Accession
- NP_006049
-
Pathways
- Activation of Innate immune Response
Target
-